Newsletter Subject

Vitamin C Flops for Severe COVID-19

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Wed, Oct 25, 2023 10:52 PM

Email Preheader Text

Daily Headlines Wednesday, October 25, 2023 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLI

[MEDPAGE TODAY]( Daily Headlines Wednesday, October 25, 2023 Today's Top Stories for {NAME} [INFECTIOUS DISEASE]( [Vitamin C Flops for Severe COVID-19]( [ENDOCRINOLOGY]( [Another Study Highlights Metformin's Dementia Protection Properties]( [OB/GYN]( [Excessive Weight Gain in Pregnancy Tied to Earlier Death]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Incorporating Recent Data Into Current Treatment Paradigms in Melanoma]( [PUBLIC HEALTH & POLICY]( [AI Can Be a Boon to Clinicians -- If Used Correctly, Says AMA President]( [MEETING COVERAGE]( [Drug-Coated Balloon Answers 'Embarrassing' Need for In-Stent Restenosis in U.S.]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [MEETING COVERAGE]( [Esprit Resorbable Scaffold Triumphs for Severe PAD Below the Knee]( CME SPOTLIGHT [Evidence-Based Management of Adverse Effects of Immunotherapy in Relapsed/Refractory Multiple Myeloma]( [MEETING COVERAGE]( [Neoadjuvant Cemiplimab Shows Potential as an Option for Cutaneous SCC]( [RHEUMATOLOGY]( [Major Source of Lupus Morbidity More Common in Certain Racial-Ethnic Groups]( [MEETING COVERAGE]( [Radionuclide Therapy Tops AR-Pathway Inhibitor Switch for mCRPC]( CME SPOTLIGHT [Applying the Latest Clinical Evidence and Guideline Recommendations for CAR T-cell Therapy in Non-Hodgkin Lymphoma]( [THE BREAK ROOM]( [Spell Check-Up: Can You Choose the Right Spelling?]( [MEETING COVERAGE]( [Fauci to Pediatricians: You Have a 'Reservoir of Trust' With the Public]( [PSYCHIATRY]( [Meta's Mental Health Lawsuits; Short Sleep and Depression; Inflated Psych Results?]( CME SPOTLIGHT [CAR T-Cell Therapy 101]( [MEETING COVERAGE]( [Severe Asthma in Sexual and Gender Minoritized Adults: What Can We Do?]( [MEETING COVERAGE]( [New Options Challenge Standard Treatments in EGFR-Mutant NSCLC]( [MEETING COVERAGE]( [Endoscopy Still an Option for Some 90-Year-Olds With GI Bleeds]( CME SPOTLIGHT [Advancing the Integration of CAR T-Cell Therapy in Community Oncology Centers: A Transformative Quality Improvement Initiative at a Large Community-Based Network]( [MEETING COVERAGE]( [Novel Stool RNA Test More Sensitive for Detecting Colon Cancer Versus FIT]( [MEETING COVERAGE]( [Early Experience Keeps Tendyne TMVR on Track for MR and Severe MAC]( [SPECIAL REPORTS]( [Journal Editor Fired for Hamas-Israeli Conflict Comments]( CME SPOTLIGHT [Expanding Access to Novel Treatment Approaches for Multiple Myeloma]( [PUBLIC HEALTH & POLICY]( [Senate Committee Advances NIH Director Nominee to Full Senate]( [MEETING COVERAGE]( [Tricuspid Regurgitation Device Passes in Pivotal Trial]( [MEETING COVERAGE]( [Combining TAVR, LAA Closure in Same Procedure Safe, Trial Says]( [MEETING COVERAGE]( [Using Statins With Blood Thinners Linked With Less GI Bleeding Risk]( [INFECTIOUS DISEASE]( [Convalescent Plasma Improves Survival in COVID Patients With ARDS, New Trial Shows]( # Weekly Survey [Age Cutoff for Prostate Cancer Surveillance: Good or Bad?]( No consensus has been reached on when or whether men with [low-risk prostate cancer]( can stop active surveillance[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-10-25&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

23/06/2024

Sent On

23/06/2024

Sent On

22/06/2024

Sent On

21/06/2024

Sent On

21/06/2024

Sent On

21/06/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.